“`html
New Hope for Rheumatoid Arthritis: Vagus Nerve Stimulation
Table of Contents
If your rheumatoid arthritis (RA) symptoms are bedeviling you and medication isn’t making enough of a difference, you may soon have a new option: a tiny device implanted in your neck that delivers a small zap of electricity to a critical nerve.
The U.S. Food and Drug Governance (FDA) approved the device, called the setpoint System, for adults with moderate to severe rheumatoid arthritis symptoms who either can’t effectively manage their symptoms with biologics or targeted medications or can’t tolerate side effects from these drugs.
The SetPoint System delivers a brief, low-voltage jolt of electricity to the vagus nerve once a day to reduce the inflammation that exacerbates RA symptoms. The vagus nerve runs from the brain to the digestive tract and controls a wide variety of bodily functions, including immune responses.
How Does the SetPoint System Work?
Existing medications have limitations. They don’t work for everyone, and some people experience unpleasant side effects. The SetPoint System offers a different approach.By stimulating the vagus nerve, it aims to modulate the immune system and reduce inflammation without the systemic effects of drugs.
HereS a breakdown of the process:
- Implantation: A small device is surgically implanted near the vagus nerve in the neck.
- Daily stimulation: Once a day, the device delivers a mild electrical pulse.
- Immune Modulation: This stimulation influences the vagus nerve,which in turn affects the immune system,reducing inflammation.
Clinical Trial Results
The FDA approval was based on data from a clinical trial. Participants who received vagus nerve stimulation with the SetPoint System experienced significant improvements in their RA symptoms compared to those who received a sham procedure. Specifically, patients reported:
Reduced pain levels, improved joint function, and decreased use of pain medication.
The trial demonstrated that the SetPoint System could provide meaningful relief for individuals struggling to manage their RA with conventional treatments.
Who is a Good Candidate?
The SetPoint System isn’t for everyone with RA. it’s specifically intended for adults who:
- Have moderate to severe RA symptoms.
- Have not responded adequately to biologics or targeted medications.
- Cannot tolerate the side effects of these medications.
A thorough evaluation by a rheumatologist is necessary to determine if the SetPoint System is an appropriate treatment option.
Potential Risks and considerations
As with any medical procedure,there are potential risks associated with the SetPoint System.These may include:
- Surgical complications (infection, bleeding).
- Device malfunction.
- temporary hoarseness or voice changes.
- Pain at the implantation site.
It’s crucial to discuss these risks with your doctor before considering the procedure